Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Detailed comparison on NAV, returns, risk, holdings and cost
Growth of each fund's NAV over the selected period, rebased to 0%
Trailing risk-adjusted performance measures
Nil - If units of the Scheme are redeemed or switched out up to 12% of the units within 90 days from the date of allotment. 1.00% of the applicable NAV, If units of the scheme are redeemed or switched out in excess of the limit within 90 days from the date of allotment. Nil, If units of scheme are redeemed or switched out after 90 days from the date of allotment.
NIL. |
 Gland Pharma LtdEquity | 3.93% |
| , , , , , |
| Managing Since | 07 Apr 2026 | 16 Jan 2024 |
|---|
Growth of each fund's NAV over the selected period, rebased to 0%
